Breast Cancer

Metastatic Right Breast Carcinoma

Female, 46 years

Patient Internal ID: 369461769

ICD-10 code

C50.8 Malignant Neoplasm of Overlapping Lesion of Breast

Diagnosis (Incl. Metastases/Stage) and Year

March 2020
Carcinoma of Right Breast cT4N2M1 G2 ER(+), PR(+), HER2 (-), KI67 – 30%, Stage IV. Metastases to Liver, Ovary and Pancreas.

Previous Treatment

Chemotherapy (Fluorouracil, Adriamycin, and Cytoxan), Target Therapy (Ribociclib), Chemotherapy (Capecitabine).

Prognosis and Survival Expectation

The prognosis remains poor, the five-year survival rate for patients diagnosed with Stage IV Breast Cancer is 22%.

Treatment Provided

Autologous DCV (10 doses) and CIK (4 doses) over a period of 14 months. Additionally, the patient received Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF) as well as Mistletoe Therapy.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient is alive (now 43 months since diagnosis) and continues to receive Chemotherapy of Capecitabine as well as Mistletoe Injections. It can be concluded that the addition of Immunotherapy, alongside Chemotherapies, has benefited the patient with stable disease and disease control.